The Health and Labor Inspection Body of Armenia has ordered the suspension and recall of a specific batch of the medication Sanovasc (acetylsalicylic acid) 75 mg film-coated tablets.
According to the agency, on June 1, 2026, a recall order was issued to RICHTER-LAMBRON JV LLC concerning batch 90624 of the product:
Medication: Sanovasc (Acetylsalicylic Acid)
Strength: 75 mg
Packaging: 30 tablets (3 blisters × 10 tablets)
Manufacturer: Irbitsky Chemical Pharmaceutical Plant
Affected Batch: 90624
The decision was based on findings from the Scientific Centre of Drug and Medical Technology Expertise, which identified a Class II quality defect during laboratory testing.
According to the expert conclusion, the affected batch failed to meet specification requirements due to non-compliance related to the «related impurities» parameter.
Important Notice for Consumers
Citizens are advised to:
Check the batch number of any Sanovasc 75 mg tablets they are using.
Avoid using tablets from batch 90624.
Contact a healthcare professional or pharmacist if they possess the affected batch and require guidance on replacement or alternative treatment.
The Health and Labor Inspection Body urges the public to remain attentive and follow the recall notice to ensure medication safety.
